Form 4 Tracker
Apogee Therapeutics, Inc.
APGE

42 insider filings · Latest: Sep 3, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Nov 11, 2025Nov 12 12:03 PMJANE HENDERSON
Proposed Sale
1,000$56.77$56.8K—

View →

Nov 5, 2025Nov 5 9:17 PMCARL DAMBKOWSKI
Proposed Sale
10,785$53.90$581.3K—

View →

Jul 2, 2025Jul 2 8:22 PMCARL DAMBKOWSKI
Proposed Sale
22,345$44.26$989.0K—

View →

Apr 2, 2025Apr 2 8:23 PMCARL DAMBKOWSKI
Proposed Sale
9,310$35.61$331.5K—

View →

Mar 5, 2025Mar 5 6:46 PMHENDERSON MICHAEL THOMAS
Proposed Sale
10,000$30.15$301.5K—

View →

Feb 5, 2025Feb 5 7:02 PMHENDERSON MICHAEL THOMAS
Proposed Sale
15,000$40.58$608.7K—

View →

Jan 8, 2025Jan 8 5:23 PMHENDERSON MICHAEL THOMAS
Proposed Sale
15,000$48.85$732.7K—

View →

Dec 11, 2024Dec 11 9:59 PMCARL DAMBKOWSKI
Proposed Sale
18,160$48.38$878.6K—

View →

Dec 4, 2024Dec 4 4:12 PMHENDERSON MICHAEL THOMAS
Proposed Sale
15,000$46.58$698.7K—

View →

Nov 6, 2024Nov 6 4:39 PMHENDERSON MICHAEL THOMAS
Proposed Sale
15,000$59.23$888.4K—

View →

Oct 2, 2024Oct 2 8:20 PMCARL DAMBKOWSKI
Proposed Sale
16,010$57.31$917.5K—

View →

Oct 2, 2024Oct 2 6:34 PMHENDERSON MICHAEL THOMAS
Proposed Sale
40,000$56.23$2.2M—

View →

Sep 4, 2024Sep 4 5:35 PMHENDERSON MICHAEL THOMAS
Proposed Sale
40,000$47.62$1.9M—

View →

Aug 23, 2024Aug 23 8:09 PMJANE V HENDERSON
Proposed Sale
6,000$48.26$289.6K—

View →

← Previous

Page 3 of 3

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Apr 16, 2026Apr 20 8:05 PMMichael Thomas HendersonDirector, Chief Executive Officer
Option Exercise
3,000$22.86387,012(D)

View →

Apr 1, 2026Apr 4 12:00 AMCarl DambkowskiChief Medical Officer
Option Exercise
4,125$22.86127,165(D)

View →

Mar 4, 2026Mar 7 1:00 AMCarl DambkowskiChief Medical Officer
Option Exercise
4,125$22.86131,290(D)

View →

Feb 4, 2026Feb 5 1:02 AMCarl DambkowskiChief Medical Officer
Option Exercise
4,125$22.86135,415(D)

View →

← Previous

Page 2 of 2